[2] The initial 3-year research project was called 'Information eXtraction from Images' (hence the IXI name), and funded by the UK e-science core and other industry partners.

[3] In October 2013, IXICO entered the Alternative Investment Market (AIM) of the London Stock Exchange through a reverse takeover of defunct pharmaceutical drug company Phytopharm.

Briefly known as Lawnhale, it changed its name to Phytopharm in March 1996[5] and listed on the London Stock Exchange on 25 April of the same year (LSE:PYM).

[7] By 2012, the Phytopharm group consisted of a parent company, Phytopharm plc, a wholly owned trading subsidiary, Phytotech Limited, and a dormant subsidiary, Phytodevelopments Limited.

[8] Amongst other activity, Phytopharm raised funds for research into treatment of Parkinson's disease (PD) from sources including the Michael J Fox Foundation,[9] but the company collapsed in 2013 following the failure of its main PD drug (Cogane) during clinical trials.